Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.3125
-0.0065 (-2.04%)
May 21, 2026, 10:39 AM EDT - Market open
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $6.23 million as of May 21, 2026. Its market cap has increased by 41.97% in one year.
Market Cap
6.23M
Enterprise Value
3.46M
1-Year Change
41.97%
Ranking
Category
Stock Price
$0.31
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $6.23M, a decrease of -96.99%. That is a compound annual growth rate of -59.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 6.36M | 147.59% |
| Dec 31, 2025 | 2.57M | -73.72% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acurx Pharmaceuticals | 6.94M |
| Addex Therapeutics | 6.81M |
| Aptorum Group | 6.60M |
| Xenetic Biosciences | 6.50M |
| CollPlant Biotechnologies | 6.49M |
| GeoVax Labs | 6.45M |
| Purple Biotech | 6.41M |
| XTL Biopharmaceuticals | 6.20M |